Tick exposure and prevention study for Alsace foresters
Part of Infections clinical trials.
This study looks at how foresters in Alsace are exposed to ticks and tick-borne diseases, and how to prevent them. The goal is to better protect forestry workers from these risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You work for the National Forestry Office (ONF).
- You are regularly exposed to ticks in the Alsace region of France.
- You do forestry work as part of a group.
- You agree to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your immune system responds to the bacteria that causes Lyme disease. It may help doctors better understand the disease and improve treatment. The trial includes people with a specific form of Lyme called acrodermatitis chronica atrophicans (a skin condition) and healthy volunteers.
This study looks at people in Alsace, France, who have been diagnosed with anaplasmosis (a tick-borne infection). It aims to understand the disease's patterns and symptoms.
This trial asks general practitioners in France to complete a survey about their knowledge of tick-borne encephalitis (a virus spread by ticks that can cause brain swelling). It helps researchers understand how well doctors know about this disease and how to prevent it.
This study looks at people who got a serious form of Lyme disease while being treated with a type of biologic drug called an anti-CD20 (such as rituximab). The goal is to learn more about these cases and improve care. You may join if you had Lyme disease confirmed by a DNA test within two years of taking this medicine.
This study looks at how the body reacts to tick bites, specifically to understand alpha-gal syndrome—a condition that can cause allergic reactions to red meat. If you had a recent tick bite and can provide the tick, you may be able to help researchers learn more.
This study looks at cases of babesiosis, a rare tick-borne disease, in France from 2000 to 2024. It aims to understand how the disease affects people.
Hear when a new Lyme Borreliosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.